359 filings
Page 8 of 18
8-K
ATXI
Avenue Therapeutics Inc
8 Mar 22
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:01pm
8-K
ATXI
Avenue Therapeutics Inc
16 Feb 22
Avenue Therapeutics Announces Outcome of FDA Advisory Committee Meeting on IV Tramadol
7:39am
SC 13G
Nantahala Capital Management, LLC
14 Feb 22
AVENUE THERAPEUTICS / Nantahala Capital Management ownership change
8:31am
8-K
ATXI
Avenue Therapeutics Inc
11 Feb 22
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
12:00am
SC 13G/A
ATXI
Avenue Therapeutics Inc
9 Feb 22
AVENUE THERAPEUTICS / VANGUARD ownership change
3:24pm
SC 13G/A
ATXI
Avenue Therapeutics Inc
9 Feb 22
AVENUE THERAPEUTICS / VANGUARD INDEX FUNDS ownership change
3:24pm
8-K
ATXI
Avenue Therapeutics Inc
7 Jan 22
Departure of Directors or Certain Officers
4:15pm
4
ATXI
Avenue Therapeutics Inc
21 Dec 21
AVENUE THERAPEUTICS / JAY D KRANZLER ownership change
4:26pm
4
ATXI
Avenue Therapeutics Inc
21 Dec 21
AVENUE THERAPEUTICS / Neil Herskowitz ownership change
4:26pm
4
ATXI
Avenue Therapeutics Inc
21 Dec 21
AVENUE THERAPEUTICS / Curtis Gale Oltmans ownership change
4:24pm
3
Curtis Gale Oltmans
21 Dec 21
AVENUE THERAPEUTICS / Curtis Gale Oltmans ownership change
4:23pm
4
ATXI
Avenue Therapeutics Inc
20 Dec 21
AVENUE THERAPEUTICS / Lucy Lu ownership change
5:08pm
4
Vazzano Joseph Walter
20 Dec 21
AVENUE THERAPEUTICS / Joseph Walter Vazzano ownership change
5:07pm
S-8
ATXI
Avenue Therapeutics Inc
17 Dec 21
Registration of securities for employees
8:31am
8-K
ATXI
Avenue Therapeutics Inc
16 Dec 21
Submission of Matters to a Vote of Security Holders
4:16pm
8-K
ATXI
Avenue Therapeutics Inc
13 Dec 21
Entry into a Material Definitive Agreement
9:23am
424B5
ATXI
Avenue Therapeutics Inc
13 Dec 21
Prospectus supplement for primary offering
9:19am
EFFECT
ATXI
Avenue Therapeutics Inc
13 Dec 21
Notice of effectiveness
12:15am
424B5
ATXI
Avenue Therapeutics Inc
10 Dec 21
Prospectus supplement for primary offering
5:25pm
CORRESP
ATXI
Avenue Therapeutics Inc
9 Dec 21
Correspondence with SEC
12:00am